- Business Wire•14 days ago
Acorda Therapeutics, Inc. will host a conference call and webcast to report its first quarter 2017 financial results and pipeline updates on Thursday, April 27 at 8:30 a.m.
- Bloomberg•17 days ago
More than two years after hedge fund manager Kyle Bass started his quixotic crusade to challenge pharmaceutical patents he said lead to inflated drug prices, he doesn’t have much to show for it.
- PR Newswire•19 days ago
ACORDA NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics Inc. To Contact The Firm
NEW YORK, April 7, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Acorda Therapeutics Inc. ("Acorda" or the ...
ACOR : Summary for Acorda Therapeutics, Inc. - Yahoo Finance
Acorda Therapeutics, Inc. (ACOR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||15.15 x 100|
|Ask||25.00 x 300|
|Day's Range||16.05 - 16.60|
|52 Week Range||15.60 - 33.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-21.57|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|